Rare solid and cystic presentation of hemangiopericytoma/ solitary fibrous tumor: a case report

[1]  J. Martín-Broto,et al.  A Comprehensive Review on Solitary Fibrous Tumor: New Insights for New Horizons , 2021, Cancers.

[2]  R. Eils,et al.  Gene expression in Solitary Fibrous Tumors (SFTs) correlates with anatomical localization and NAB2-STAT6 gene fusion variants. , 2021, The American journal of pathology.

[3]  Zui Tan,et al.  Hemangiopericytoma: Incidence, Treatment, and Prognosis Analysis Based on SEER Database , 2020, BioMed research international.

[4]  J. Wunder,et al.  RNA expression profiling reveals PRAME, a potential immunotherapy target, is frequently expressed in solitary fibrous tumors , 2020, Modern Pathology.

[5]  M. Tanahashi,et al.  Solitary fibrous tumor of the pleura with marked cystic degeneration: a case report , 2020, Surgical Case Reports.

[6]  Z. Ryoo,et al.  NAB2-STAT6 fusion protein mediates cell proliferation and oncogenic progression via EGR-1 regulation. , 2020, Biochemical and biophysical research communications.

[7]  C. Poiană,et al.  Cystic appearance - a new feature of solid fibrous tumours in the lacrimal gland: a case report with literature review , 2019, Diagnostic Pathology.

[8]  L. Shang,et al.  A DSTYK mutation activates ERK1/2 signaling to promote intraspinal dissemination in a case of solitary fibrous tumor/hemangiopericytoma , 2019, Laboratory Investigation.

[9]  Heather N. Hayenga,et al.  Intraspinal Dissemination and Local Recurrence of an Intracranial Hemangiopericytoma. , 2019, World neurosurgery.

[10]  J. Blay,et al.  Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial. , 2019, The Lancet. Oncology.

[11]  I. Baldi,et al.  Increasing incidence of central nervous system (CNS) tumors (2000–2012): findings from a population based registry in Gironde (France) , 2018, BMC Cancer.

[12]  K. Ashkan,et al.  Surveillance for metastatic hemangiopericytoma-solitary fibrous tumors-systematic literature review on incidence, predictors and diagnosis of extra-cranial disease , 2018, Journal of Neuro-Oncology.

[13]  Krishnakumar Subramanian,et al.  A rare case of giant multicystic solitary fibrous tumor of the orbit , 2018, Orbit.

[14]  A. D. Dei Tos,et al.  Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour. , 2017, European journal of cancer.

[15]  T. Tominaga,et al.  Intraspinal dissemination of intracranial hemangiopericytoma: Case report and literature review , 2016, Surgical neurology international.

[16]  A. Bellizzi,et al.  The NAB2-STAT6 gene fusion in solitary fibrous tumor can be reliably detected by anchored multiplexed PCR for targeted next-generation sequencing. , 2016, Cancer genetics.

[17]  I. Judson,et al.  Pazopanib as first line treatment for solitary fibrous tumours: the Royal Marsden Hospital experience , 2015, Clinical Sarcoma Research.

[18]  Su Jin Lee,et al.  Successful use of pazopanib for treatment of refractory metastatic hemangiopericytoma , 2014, Clinical Sarcoma Research.

[19]  S. Lo,et al.  Rare Primary Central Nervous System Tumors , 2014, Rare tumors.

[20]  L. Mariani,et al.  Response to chemotherapy of solitary fibrous tumour: a retrospective study. , 2013, European journal of cancer.

[21]  Wei-Lien Wang,et al.  The role of chemotherapy in advanced solitary fibrous tumors: a retrospective analysis , 2013, Clinical Sarcoma Research.

[22]  R. Gomes,et al.  Primary Malignant Cystic Solitary Fibrous Tumour of the Spleen , 2013, Indian Journal of Surgical Oncology.

[23]  K. Pienta,et al.  Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing , 2013, Nature Genetics.

[24]  A. D. Dei Tos,et al.  Sunitinib malate in solitary fibrous tumor (SFT). , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[25]  J. Wen,et al.  Recurrent Meningeal Hemangiopericytoma with Multiple Metastasis and Hypoglycemia: A Case Report , 2012, Case reports in medicine.

[26]  Y. Robin,et al.  Solitary Fibrous Tumors and So-Called Hemangiopericytoma , 2012, Sarcoma.

[27]  A. Lazar,et al.  Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor , 2011, Cancer.

[28]  V. Elner,et al.  Cystic solitary fibrous tumor of the orbit. , 2010, Archives of ophthalmology.

[29]  P. Cornu,et al.  Cystic Intraventricular Solitary Fibrous Tumor , 2007, American Journal of Neuroradiology.

[30]  D. Kondziolka,et al.  Radiosurgery for Treatment of Recurrent Intracranial Hemangiopericytomas , 2002, Neurosurgery.

[31]  K. Kishi,et al.  Hypoglycemia induced by secretion of high molecular weight insulin-like growth factor-II from a malignant solitary fibrous tumor of the pleura. , 2001, Internal medicine.

[32]  A. Obwegeser,et al.  Vascular endothelial growth factor (VEGF) is elevated in brain tumor cysts and correlates with tumor progression , 2000, Acta Neuropathologica.

[33]  K. Pavelić,et al.  The expression and role of insulin-like growth factor II in malignant hemangiopericytomas , 1999, Journal of Molecular Medicine.

[34]  S. Nicosia,et al.  Vascular endothelial growth factor levels in ovarian cyst fluid correlate with malignancy. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[35]  B. Scheithauer,et al.  Management of recurrent meningeal hemangiopericytoma , 1998, Cancer.

[36]  Jianliang Chen,et al.  Intracranial Meningeal Hemangiopericytomas : Articles Review and Case Report , 2019 .